KLKnut N. Leknes

Knut N. Leknes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Knut N. Leknes has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Olav E. Bøe

    5 shared publications
  • Ulf M. E. Wikesjö

    Laboratory for Applied Periodontal & Craniofacial Regeneration, Medical College of Georgia, Augusta, GA, USA

    3 shared publications
  • Cristiano Susin

    Laboratory for Applied Periodontal & Craniofacial Regeneration, Medical College of Georgia, Augusta, GA, USA

    2 shared publications
  • Giuseppe Polimeni

    Laboratory for Applied Periodontal & Craniofacial Regeneration, Medical College of Georgia, Augusta, GA, USA

    2 shared publications
  • Harald Nesse

    2 shared publications
  • Jie Yang

    Department of Oral & Maxillofacial Pathology, Medicine & Surgery, Division of Oral and Maxillofacial Radiology, Temple University School of Dentistry, Philadelphia, PA, USA

    2 shared publications

Latest Publications

  • Profesjonell hygieneoppfølging av unge pasientar med fast kjeveortopedisk apparatur

    by Malene Øen, Ingvild E. Sundby, Marit Midtbø, Olav E. Bøe, Knut N. Leknes

    English summary: The effect of oral health promotion in young patients with fixed orthodontic appliance. A 12-month follow-up study 588 - 94. Many patients experience an increased incidence of gingivitis during fixed orthodontic treatment. The aim of this study was to evaluate the effect of extra professional oral hygiene instruction during a 12-month orthodontic treatment period. The participants in this prospective, clinical study were referred patients from public health service in Sunnhordland. Included patients were randomly allocated to a test (16) or a control group (14). The test group received oral hygiene instruction and cleaning at baseline and 1, 3, 6, 9, and 12 months, whereas the control group received the same treatment only at baseline and 12 months. In addition to microbial sampling, the following clinical variables were recorded: Probing depth, bleeding on probing, dental plaque, and the distance from the gingival edge of the bracket to the gingival margin. Generally, this study showed a similar worsening of the gingival conditions for both groups during the 12-month treatment period. Fixed orthodontic treatment resulted in increased bleeding on probing for the test (p = 0.04), increased numbers of probing depths 3 mm, and reduced distance from brackets to gingival margin for both groups (p < 0.001). The number of patients positive for Porphyromonas gingivalis increased during the 12-month observation period for both groups. However, the increase was only significant for the control group (p = 0.02). This study shows that fixed orthodontic treatment may have detrimental effects on the gingival conditions among 12-year old children even after extra professional oral hygiene instruction. Additional oral health promotion did not result in gingival improvement for this group of patients.

  • Er:YAG laser in the treatment of periodontal sites with recurring chronic inflammation: a 12‐month randomized, controlled clinical trial

    by Ivar Krohn‐Dale, Bøe, Olav E., Morten Enersen, Knut N. Leknes

    Aim: The objective of this randomized, controlled clinical trial was to compare the clinical and microbiological effects of pocket debridement using erbium‐doped: yttrium, aluminium and garnet (Er:YAG) laser with conventional debridement in maintenance patients.Material & Methods: Fifteen patients, all smokers, having at least four teeth with residual probing depth (PD) ≥5 mm were recruited. Two pockets in two jaw quadrants were randomly assigned to subgingival debridement using an Er:YAG laser (test) or ultrasonic scaler/curette (control) at 3‐month intervals. Relative attachment level (RAL), PD, bleeding on probing and dental plaque were recorded at baseline and at 6 and 12 months. Microbiological subgingival samples were taken at the same time points and analysed using a checkerboard DNA‐DNA hybridization technique.Results: A significant decrease in PD took place in both treatments from baseline to 12 months (p < 0.01). In the control, the mean initial PD decreased from 5.4 to 4.0 mm at 12 months. For the test, a similar decrease occurred. No significant between‐treatment differences were shown at any time point. The mean RAL showed no overall significant inter‐ or intra‐treatment differences (p > 0.05). No significant between‐treatment differences were observed in subgingival microbiological composition or total pathogens.Conclusion: The results failed to support that an Er:YAG laser may be superior to conventional debridement in the treatment of smokers with recurring chronic inflammation. This appears to be the first time that repeated Er‐YAG laser instrumentation has been compared with mechanical instrumentation of periodontal sites with recurring chronic inflammation over a clinically relevant time period.


  • Periodontal forbehandling - en forutsetning for et vellykket resultat ved innsetting av tannimplantater på periodontittdisponerte pasienter

    by Jørgen Frostad, Knut N. Leknes

    English summary: Periodontal treatment - a prerequisite for a successful outcome following implant therapy in periodontally compromised patients 428 - 33. Despite the predictability of dental implants for orofacial rehabilitation, a small but significant subset of patients continues to experience implant failure. It is the therapist''s responsibility to acquire sufficient knowledge to identify patients at risk for dental implant failure. Patient evaluation and treatment planning have to focus on systemic and local host factors. Most reviews of implant treatment and associated risk factors conclude that there are no absolute systemic or local contraindications to implant placement. However, age, smoking, diabetes, head or neck radiation therapy, and the quality and quantity of bone available at the implant site have an impact on the failure rate. To be covered by the national insurance, an absolute requirement from January 2007 is that the oral cavity is free of pathology and oral infections prior to implant placement. This article reviews literature focusing on the importance of reducing the oral infection by periodontal treatment of the residual dentition before placement of dental implants. Elimination of periodontal lesions, establishment of a high standard of infection control, and regular recalls for supportive care are critical measures to achieve long-term success of implant therapy in the periodontally compromised patient. The presented case illustrates periodontal treatment before implant placement.

  • Implantatforankret protetisk behandling

    by Maren Johnsen Rishaug, Anja Nyland Simensen, Kristin S. Klock, Olav E. Bøe, Harald Nesse, Knut N. Leknes

    English summary: Implant treatment: An assessment of factors having an impact on the choice of therapy 1036–41. Implant therapy has become an increasingly common treatment option for tooth replacement. The indications, technical possibilities and patients’ expectations of implant treatment have been expanded. In this context the aim was to study why the patients choose implant therapy, where the patients received information about implant treatment, and which factors are important for their choice of therapy. A questionnaire was sent to patients scheduled for evaluation at three different clinics. A total of 56 questionnaires were returned (response rate 40.3 %). The most frequent factors for the patients’ final choice of therapy were good chewing function and aesthetics, and 62.5 % stated that the cost of treatment was not a critical factor. More than 60 % of the respondents received their first information about implant treatment from a dentist and 72.7 % thought that they received the most valuable information from the dentist. More than 2/3 felt they possess little knowledge about implant treatment. Dentists are good at giving the patients information and presenting implants as a treatment option. Patients’ knowledge level indicates, however, that patients lack sufficient information about disadvantages and complications relating to treatment. Dentists should therefore ensure that patients receive information about all aspects of implant therapy.

  • Laserbehandling av infeksjoner ved tenner og dentale implantater

    by Knut N. Leknes, Miriam E. Alstad, Ellen Bruzell

    English summary: Laser treatment of periodontal and peri-implant infections 700 – 6. Laser therapy has for many years been a successful treatment approach in several areas of general medicine. A dental laser survey among general dental practitioners and specialists in periodontics in 2008, reported that 53 % of dentists and 36 % of specialists used lasers in their management of gum diseases. The numbers have to be interpreted with caution; nevertheless, laser therapy appears to be an increasingly common treatment option also in the dental clinic. Having in mind the rather aggressive marketing of lasers in the treatment of periodontal and peri-implant infections, this article aims to describe the mode of action and critically evaluate the merits of laser therapy. Different types of lasers are available, but presently the Er:YAG laser seems to be most promising in dentistry. The main conclusion is that laser application in non-surgical periodontal and surgical peri-implantitis therapies provides no beneficial effect over traditional treatment procedures. With the wavelengths and power settings used, no major adverse effects have been reported for dental use of the Er:YAG laser. However, there is a need for broader basis of well-designed clinical trials for drawing definite conclusions about the long-term effect of laser treatment.

  • Enamel Matrix Derivative Versus Bioactive Ceramic Filler in the Treatment of Intrabony Defects: 12‐Month Results

    by Knut N. Leknes, Kari‐Mette Andersen, Olav E. Bøe, Ragnfrid J. Skavland, Jasim M. Albandar

    Background: This study examined the clinical efficacy of enamel matrix derivative (EMD) and bioactive ceramic filler (BCF) in the treatment of intrabony periodontal defects and evaluated factors influencing the treatment outcome.Methods: Thirteen chronic periodontitis patients, 41 to 74 years of age, who had two proximal intrabony defects in different jaw quadrants with ≥3 mm vertical radiographic bone loss were selected for this study. After initial therapy, the sites in each patient were randomly assigned to EMD or BCF treatment. Clinical attachment level (CAL), probing depth (PD), tooth mobility (TM), gingival recession (GR), bleeding on probing, and dental plaque were recorded at baseline and at 6 and 12 months. At surgery, the intrabony component was characterized by recording the number of bony walls, distance in millimeters from the buccal crest (BC) to the most apical point of the defect, distance from the cemento‐enamel junction (CEJ) to the BC, and the mesio‐distal width of the defect at the level of the bony crest.Results: BCF treatment resulted in a significant gain in proximal CAL (P = 0.005) and a reduction in proximal PD at 6 months (P P = 0.001), whereas the gain in proximal CAL approached significance (P = 0.056). Mean GR increased significantly from baseline to 6 months in both groups (P = 0.001). Regression analysis revealed that within the EMD group, smoking and TM negatively influenced the gain of attachment, whereas within the BCF group, gingival recession increased with age, increasing CEJ to BC distance, and increasing mesial‐distal width of the defect.Conclusions: The gain in proximal attachment after treating intrabony defects by flap surgery with BCF was significant (P = 0.004) and twice that following treatment with EMD (P = 0.056). Patient and site variables affected the clinical outcome differently.


  • Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐2: radiographic observations

    by Knut N. Leknes, Jie Yang, Mohammed Qahash, Giuseppe Polimeni, Cristiano Susin, Ulf M. E. Wikesjö

    Objectives: Effective carrier technologies and dosing appear critical for the successful use of bone morphogenetic proteins (BMPs). This study evaluated radiographically the potential of a purpose‐designed titanium porous‐oxide implant surface combined with recombinant human BMP‐2 (rhBMP‐2) to stimulate alveolar ridge augmentation.Material and methods: Twelve young‐adult Labrador dogs were used. Three 10‐mm titanium implants per jaw quadrant were placed 5 mm into the alveolar ridge following extraction of the premolar teeth and reduction of alveolar ridge. Six animals received implants coated with rhBMP‐2 at 0.75 or 1.5 mg/ml randomized to contralateral jaw quadrants. Another six animals received implants coated with rhBMP‐2 at 3 mg/ml or uncoated control using the same split‐mouth design. The mucoperiosteal flaps were advanced, adapted, and sutured to submerge the implants. Radiographic registrations were made immediately postsurgery (baseline), and at weeks 4 and 8 (end of study).Results: rhBMP‐2‐coated implants exhibited robust radiographic bone formation extending to and above the implant platform from week 4 (PConclusions: The titanium porous‐oxide surface serves as an effective carrier for rhBMP‐2, showing a clinically significant potential to stimulate local bone formation. With the carrier technology used, therapeutic dosage appears to be in the range of 0.75–1.5 mg/ml.


  • Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐7 (rhBMP‐7/rhOP‐1): radiographic observations

    by Knut N. Leknes, Jie Yang, Mohammed Qahash, Giuseppe Polimeni, Cristiano Susin, Ulf M. E. Wikesjö

    Aim: The objective of this study was to radiographically evaluate the potential of a purpose-designed titanium porous-oxide implant surface coated with recombinant human bone morphogenetic protein-7 (rhBMP-7), also known as recombinant human osteogenic protein-1 (rhOP-1), to stimulate alveolar ridge augmentation. Material and Methods: Six young-adult Hound Labrador mongrel dogs were used. Three 10 mm titanium oral implants per jaw quadrant were placed 5 mm into the alveolar ridge in the posterior mandible following surgical extraction of the pre-molar teeth and reduction of the alveolar ridge leaving 5 mm of the implants in a supra-alveolar position. The implants had been coated with rhBMP-7 at 1.5 or 3.0 mg/ml and were randomized to contralateral jaw quadrants using a split-mouth design. The mucoperiosteal flaps were advanced, adapted, and sutured to submerge the implants. Radiographic registrations were made immediately post-surgery (baseline), and at weeks 4 and 8 (end of study). Results: rhBMP-7-coated implants exhibited robust radiographic bone formation. At 8 weeks, bone formation averaged 4.4 and 4.2 mm for implants coated with rhBMP-7 at 1.5 and 3.0 mg/ml, respectively. There were no significant differences between the rhBMP-7 concentrations at any observation interval. A majority of the implant sites showed voids within the newly formed bone at week 4 that generally resolved by week 8. The newly formed bone assumed characteristics of the resident bone. Conclusions: The titanium porous-oxide implant surface serves as an effective carrier for rhBMP-7 showing a clinically significant potential to stimulate local bone formation.


  • Kroneforlenging – når er dette en nødvendig preprotetisk behandling?

    by Ragnhild Byberg, Åsta Wathne, Harald Nesse, Knut N. Leknes

    English summary: Crown lengthening – when is this a necessary pre-prosthetic therapy 368 – 74. Periodontal health is of paramount importance for all teeth, both sound and restored. When the clinical crowns of teeth are dimensionally inadequate, it is hard to accomplish an esthetically and biologically acceptable restoration. Crown lengthening is a periodontal resective procedure, aiming at removing supporting periodontal structure to gain sound tooth structure above the alveolar crest level. The crown lengthening procedure can be limited to the soft tissues when there is enough gingiva coronal to the alveolar bone. However, the majority of cases will involve bone recontouring as well as gingival resection to accommodate esthetic and functional demands. This article reviews the concept of biologic width, indications and contraindications for crown lengthening, and surgical techniques. Four cases are presented utilizing crown lengthening as an integral part of treatment to restore teeth and to correct compromised esthetic smile.


  • Suturmateriale ved oralkirurgiske inngrep

    by Knut N. Leknes

    English summary: Suture materials in oral surgical procedures 828 – 33. A variety of suture materials are in current use to close incisional, excisional, as well as traumatic wounds in the oral cavity. Generally, sutures are placed to stabilize detached tissue flaps during initial phases of the wound healing process. An ideal suture should be biocompatible, easy to handle, cause minimum tissue reactions and have low cost. By placing sutures the already traumatized tissues are perforated and thereby exposed to new micro wounds. The entrance as well as the exit sites represent a potential locus for bacterial accumulation and penetration along the suture track. Preference of suture materials is by and large dictated by tradition and for ease in handling. The purpose of the present paper is to describe and discuss the most common suture materials on the market, with particular emphasis on chemical, physical and biological factors when placing a suture. Several studies have demonstrated that placement of sutures in gingival tissues elicits an inflammatory reaction and that the magnitude of this reaction may vary with the suture material. Braided silk sutures apparently cause a more extensive inflammatory tissue reaction in an environment characterized by moisture and infectious potential.